Prolotherapy with Phenol (Dextrose 25%, Glycerin 25%, Phenol 2.5%, QS SWI), 100 mL vial, Rx Only,...
FDA Drug Recall #D-1830-2015 — Class I — August 17, 2015
Recall Summary
| Recall Number | D-1830-2015 |
| Classification | Class I — Serious risk |
| Date Initiated | August 17, 2015 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Hartley Medical Center Pharmacy, Incorporated |
| Location | Long Beach, CA |
| Product Type | Drugs |
| Quantity | 10 vials |
Product Description
Prolotherapy with Phenol (Dextrose 25%, Glycerin 25%, Phenol 2.5%, QS SWI), 100 mL vial, Rx Only, Hartley Medical, (888) 671-2888
Reason for Recall
Non-Sterility: Hartley Medical Center Pharmacy, Inc. is recalling Prolotherapy with Phenol due to non-sterility concerns.
Distribution Pattern
CA and NV
Lot / Code Information
Lot: RX # 321608, Exp. 11/01/2015
Other Recalls from Hartley Medical Center Pharmacy, Inco...
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0750-2016 | Class II | Hydromorphone HCL 25 mg/ml, vol. 40 ml syringe,... | Feb 4, 2016 |
| D-0744-2016 | Class II | Morphine Sulfate 20 mg/ml/Bupivacaine HCL 11.3 ... | Feb 4, 2016 |
| D-0746-2016 | Class II | Hydromorphone HCL 10 mg/ml/Bupivacaine HCL 30 m... | Feb 4, 2016 |
| D-0743-2016 | Class II | Morphine Sulfate 0.6 mg/ml, vol. 200 ml syringe... | Feb 4, 2016 |
| D-0745-2016 | Class II | Morphine Sulfate 50 mg/ml/Bupivacaine HCL 24 mg... | Feb 4, 2016 |
Frequently Asked Questions
Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.